Navigation Links
DRC's Metrigraphics Announces Family of Micro-Induction Coils for Implanted and Traditional Medical Applications
Date:6/3/2008

-- New Advanced Coils Offer Design Flexibility and Transmission and

Induction Functionality -- Medical Design & Manufacturing East DRC's Metrigraphics Division Booth

#2078

NEW YORK, June 3 /PRNewswire-FirstCall/ -- Dynamics Research Corporation's Metrigraphics Division (Nasdaq: DRCO), a world-leading precision manufacturer specializing in the fabrication of customized micro-components and micro-circuits, announced today a new family of micro-induction coils designed for use in implanted medical applications and traditional biomedical devices. The micro-induction coils are equipped with radio frequency signal transmission and signal and power induction capabilities, thereby eliminating the potential harmful effects to the human body posed by battery-operated implantable medical devices.

"We are committed to delivering quality, reliability and innovation with every product we make whether it's for the medical device, telecommunications, semiconductor or biotech industry," said Randy Sablich, Vice President and General Manager of DRC's Metrigraphics Division. "DRC's Metrigraphics Division recognizes the difference that our precision micro-components make for our customers and we are honored to be working with many of the innovators making medical breakthroughs."

With over 160 coil variations prototyped, Metrigraphics offers customers the flexibility in process technology, substrate material, size, induction and tolerance ranges and functionality to meet the most rigorous technical specifications not fully addressed by other manufacturers. The new micro-induction coils are applicable for a variety of medical applications including miniature loop antennas f
'/>"/>

SOURCE Dynamics Research Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ov. 6 BioSpecifics Techn...l company developing first-in-class collagenase-ba...s for the third quarter ended September 30, 2009. ... of this year, the FDA,s Arthritis Advisory Commit...e approval of XIAFLEX(TM) for the treatment of Dup...
(Date:11/6/2009)..., Nov. 6 ,, 3Q09 C...f Qutenza(TM) E.U. Marketing Authorization to Aste...s in commercial readiness activities Expanded man... Marketing; and Director, Commercial Operations A...and Audit Committee chairman , Upcoming 200...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personali... to take place on February 22-24, 2010 in Philadel...ence we will highlight key issues in forming partn...r experiences. , Minneapo... Arrowhead’s 2010 Personalized Medicine Par...
(Date:11/5/2009)... Nov. 5 DSM Pharmaceutical Product... alliance with Galenix, Saint Jean D,Illac, France... manufacturing partner for Galenix commercial prod... collaborate on business development opportunities...based on the strength of Galenix in drug product d...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...., April 21 ,Monogram Biosciences, Inc., (Nasdaq: ...all on Thursday, May 1, 2008 at 4:30 p.m. (Eastern...ults. The call will be hosted by,Mr. William D. Yo...e in the live teleconference, please call (877) 54..., fifteen minutes before the,conference begins. Li...
...ca Inc., an Atlanta-based,company specializing in ...tained a commitment of $2.3 million in financing f...s continued marketing efforts in the UK and,ongoin...//www.newscom.com/cgi-bin/prnh/20070808/CLW014LOGO...tures, Novartis Venture,Funds, the ATDC Seed Capit...
...Novavax, Inc.,(Nasdaq: NVAX ) a clinical-stage va...hvi, President and Chief Executive Officer, will b... 11:25 a.m. on April 23, 2008 in,Washington D.C. D...,s,strategy, research and development progress., ...the Vaccine Industry,Excellence (VIE) Awards 2008 ...
Other Biology Technology:Monogram Biosciences Announces First Quarter 2008 Financial Results Conference Call 2Biofisica Obtains $2.3 Million in Financing From Investors 2
(Date:11/5/2009)...ity have developed synthetic molecules capable of ...V-infected cells, as well as to prostate cancer ce...nal of the American Chemical Society , could lead .... , The molecules called "antibody-recruiting ...uiting molecule targeting prostate cancer" (ARM-P)...
(Date:11/4/2009)...ng Beach and Riverside are responsible for a signi... and the true impact of air pollution and ship emi...ed, according to researchers at the University of ...ppears in an online edition of the American Journ...of all childhood asthma cases in Long Beach and si...
(Date:11/4/2009)...ceived more than $10 million in research grants fr...imulus program, bringing thetotal amount of stimul...on. Thirty-three projects achieved stimulus fundi.... , "The university has thoughtfully undertaken ...y excellence to federal agency priorities. Throug...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USC study finds big air pollution impacts on local communities 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 1HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 2HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 3Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 1Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 2Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 3Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 4Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive 28R 29 13823 5Service Dogs Help Traumatized Veterans Heal 56119 1Service Dogs Help Traumatized Veterans Heal 56119 2Service Dogs Help Traumatized Veterans Heal 56119 3
... was domesticated from its wild ancestor more than...ered by researchers in the Mexico,s Central Balsas...e -- by 1200 years -- for the presence and use of ...hony Ranere of Temple University and Dolores Piper...istory, reported their findings in two studies -- ...
...NGTON, D.C. Using what they say is a relatively s...Medical Center have extracted stem/progenitor cell...uripotent embryonic-like stem cells. Researchers s... of morphing into any cell type that a body needs,...ecause they produced these stem cells without the ...
...STER, Mass. CellThera, a biotechnology company lo...iences and Bioengineering Center at Gateway Park, ...nced Research Projects Agency (DARPA) to extend it...he terms of the contract, CellThera, which is part...university will continue their joint efforts aimed...
Other Biology News:Researchers find the earliest evidence of domesticated maize 2Human adult testes cells can become embryonic-like 2CellThera and WPI advance in regeneration study 2
...s research demands continue to grow, the need for ...n has become necessary, especially when discerning...he innovative C1si Confocal Microscope System give...apability not available in conventional confocal s...
EasySep PE Selection Kit, Other from StemCell Technologies, Inc.
...he Fujifilm Life Science LAS-3000 imaging system c...d user interface, providing significantly improved...ies. The LAS-3000 provides significantly improved ...s including: fluorescence, chemifluorescence, chem...
...ASGIP Overhead Drive for individual and parallel a...irrer for flexible agitation of DASGIP vessels, fe...llers. ,Up to 16 overhead drives can be operated...h-pro® and cellferm-pro® for microbiology ...
Biology Products: